Why Kymera Therapeutics Shares Are Falling Today
In its Q1 earnings release, Kymera Therapeutics Inc (NASDAQ:KYMR) announced the selection of the equivalent of 100 mg, in the…
Mid-Day Market Update: Dow Jumps 100 Points; Spero Therapeutics Shares Plunge
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Tuesday.
Earnings Scheduled For May 3, 2022
Companies Reporting Before The Bell
• Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
JPMorgan Sees ‘Limited Upside Potential’ In Kymera Therapeutics’ KT-474
JPMorgan has initiated the coverage of Kymera Therapeutics Inc (NASDAQ:KYMR) with a Neutral rating and a $44 price target. Analyst Eric Joseph…
JP Morgan Initiates Coverage On Kymera Therapeutics with Neutral Rating, Announces Price Target of $44
JP Morgan analyst Eric Joseph initiates coverage on Kymera Therapeutics (NASDAQ:KYMR) with a Neutral rating and announces Price Target of $44.